MUMBAI (Reuters) – Global drugmakers, battered by recent intellectual property decisions in India, are girding for a landmark court ruling on Monday with broad consequences for their ability to sell lucrative patented medicines in the country.
read the full story about Big Pharma waits nervously on Glivec patent verdict
Leave a Reply